Skip to main content
ZYUS Life Sciences Corporation logo

ZYUS Life Sciences Corporation — Investor Relations & Filings

Ticker · ZYUS ISIN · CA9899601095 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 299 across all filing types
Latest filing 2024-11-04 Capital/Financing Update
Country CA Canada
Listing TSXV ZYUS

About ZYUS Life Sciences Corporation

https://www.zyus.com/

ZYUS Life Sciences Corporation is a clinical-stage life sciences company dedicated to the development and commercialization of novel, non-opioid pharmaceutical drug candidates. The company focuses on proprietary cannabinoid-based therapeutics, or phyto-therapeutics, targeting the treatment of chronic and neuropathic pain. ZYUS's vision is to redefine the standard of care in pain management by developing evidence-based alternatives to conventional treatments, including opioids and NSAIDs. The core business involves advancing these drug product candidates through clinical trials, exemplified by the ongoing Phase 2a UTOPIA-1 trial evaluating a novel non-opioid pain drug.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that ZYUS Life Sciences Corporation has arranged an unsecured loan from an independent director. It details the loan amount, terms, related party transaction considerations, and intended use of proceeds. There is no financial statement, comprehensive financial data, or detailed report content. The document is an update on a financing activity, specifically a loan agreement, which fits the category of Capital/Financing Update (CAP). The length and content confirm it is not a brief announcement of a report nor a full financial report. Therefore, the appropriate classification is CAP with high confidence.
2024-11-04 English
Certificate and Articles of Amendment.pdf
Share Issue/Capital Change Classification · 95% confidence The document is a Certificate of Amendment and Articles of Amendment for a corporation under the Business Corporations Act. It details changes to the corporation's name, authorized shares, and other corporate governance matters. There is no financial data, earnings information, or management discussion. The document is a formal legal filing certifying amendments to corporate articles, which aligns with announcements related to share capital and corporate structure changes. Therefore, it fits best under Share Issue/Capital Change (SHA) as it involves amendments to share classes and capital structure.
2024-10-15 English
News release - English.pdf
Regulatory Filings
2024-09-28 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed information about securities distribution, including issuer details, underwriter information, distribution dates, purchaser information, types of securities distributed, compensation related to the distribution, and regulatory compliance details. It is a regulatory filing form used to report exempt distributions of securities, which is a specific compliance disclosure rather than a financial report, earnings release, or management discussion. The document is lengthy (15,000 characters) and contains detailed regulatory data, but it is not an annual report, audit report, earnings release, or any other financial statement. It fits best under the category of Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2024-09-04 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2024-08-29 English
Interim MD&A - English.pdf
Regulatory Filings
2024-08-29 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.